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Key points 
o High altitude-induced hypoxia in humans evokes a pattern of breathing known as periodic 
breathing (PB), where the regular oscillations corresponding to rhythmic expiration and 
inspiration are modulated by slow-periodic oscillations. 
o The phase coherence between instantaneous heart rate (IHR) and respiration is shown to 
increase significantly at the frequency of periodic breathing during acute and sustained 
normobaric and hypobaric hypoxia. 
o It is also shown that polymorphism in specific genes, NOTCH4 and CAT, is significantly 
correlated with this coherence, and thus with the incidence of PB. 
o Differences in phase shifts between blood flow signals and respiratory and PB oscillations 
clearly demonstrate contrasting origins of the mechanisms underlying normal respiration 
and PB. 
o These novel findings provide better understanding of both the genetic and physiological 
mechanisms responsible for respiratory control during hypoxia at altitude, by linking genetic 
factors with cardiovascular dynamics, as evaluated by phase coherence. 
 
Abstract 
Periodic breathing (PB) occurs in most humans at high altitudes and is characterised by low-
frequency periodic alternation between hyperventilation and apnoea. 
In hypoxia-induced PB the dynamics and coherence between heart rate and respiration and 
their relationship to underlying genetic factors is still poorly understood. The aim of this 
study was to investigate, through novel usage of time-frequency analysis methods, the 
dynamics of hypoxia-induced PB in healthy individuals genotyped for a selection of 
antioxidative and neurodevelopmental genes. 
Breathing, ECG and microvascular blood flow were simultaneously monitored for 30 
minutes in 22 healthy males.  The same measurements were repeated under normoxic and 
hypoxic (normobaric (NH) and hypobaric (HH)) conditions, at real and simulated altitudes of 
up to 3800 m. Wavelet phase coherence and phase difference around the frequency of 
breathing (approximately 0.3 Hz) and around the frequency of PB  (approximately 0.06 Hz) 
were evaluated. Subjects were genotyped for common functional polymorphisms in 
antioxidative and neurodevelopmental genes. 
During hypoxia, PB resulted in increased cardiorespiratory coherence at the PB frequency. 
This coherence was significantly higher in subjects with NOTCH4 polymorphism, and 
significantly lower in those with CAT polymorphism (HH only). Study of the phase shifts 
clearly indicates that the physiological mechanism of PB is different from that of the normal 
respiratory cycle. The results illustrate the power of time-evolving oscillatory analysis 
content in obtaining important insight into high altitude physiology. In particular, it provides 
further evidence for a genetic predisposition to PB and may partly explain the heterogeneity 
in the hypoxic response. 
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Introduction 
Respiration occurs spontaneously through the coordinated action of many finely balanced 
processes within the body. The respiratory system contains chemoreceptors that 
continuously monitor the levels of blood oxygen and carbon dioxide, which in turn influence 
the breathing rate and the volume of the lungs. Continuous feedback mechanisms usually 
maintain blood oxygen and carbon dioxide levels within narrow ranges, but in extreme 
environments such as high altitudes, or when affected by certain diseases, these 
mechanisms can overcompensate or fail. One consequence of this is an amplitude 
modulation of respiration known as periodic breathing (PB). 
PB is a well-known phenomenon that may arise in healthy individuals at high altitudes 
(Berssenbrugge et al., 1983). It is defined as repetitive oscillations in breathing amplitude, 
with each cycle containing a period of hyperventilation followed by a period of apnoea. PB 
has been widely reported during sleep at altitude, causing significant sleep disturbance 
(Ainslie et al., 2013), but has also been observed during the awake state, during both rest 
and exercise (Hermand et al., 2014; Garde et al., 2015). PB-type respiration is not unique to 
those ascending to high altitudes, with similar breathing patterns being observed at sea-
level in sleep apnoea (Garde et al., 2015), newborn infants (Kelly et al., 1985) and 
pathological conditions such as heart failure. The breathing pattern observed in the latter is 
known as Cheyne-Stokes respiration (Cherniack and Longobardo, 1973). 
PB develops due to changes in the complex interactions between peripheral and central 
chemoreflexes and cerebral blood flow (Ainslie et al., 2013) induced by environmental 
changes (Burgess et al., 2008). Reduced partial pressure of oxygen in the air at high altitudes 
may induce hypoxaemia, leading to hyperventilation in order to rapidly increase blood 
oxygen levels. Increased ventilatory sensitivity during hypoxia causes ‘overshooting’ of this 
feedback system, and thus over-hyperventilation leads to hypocapnia. This then reduces the 
respiratory drive and leads to a period of apnoea. Apnoea will then cause blood CO2 levels 
to rise, and the cycle repeats, leading to periodic breathing (Hernandez and Patil, 2016). The 
extent of PB increases with the duration and severity of hypoxia (Ainslie et al., 2013), and 
the cycle length decreases with increasing altitude (Kupper et al., 2008). 
The altered respiratory pattern due to PB directly affects other systems within the body, 
including the heart rate and the blood flow. In normal conditions, respiration directly affects 
the heart rate, in a process known as respiratory sinus arrhythmia (RSA) (Hirsch and Bishop, 
1981; Elstad et al., 2018). RSA usually manifests in the frequency spectrum at the respiration 
frequency, near 0.25 Hz. Lower-frequency spectral components have also been observed in 
HRV during PB and are directly related to respiration (Leung et al., 2003);  RSA is modulated 
by hypercapnia but not mild hypoxaemia (Tzeng et al., 2007). These interactions between 
breathing and heart rate have been used to quantify PB (Garde et al., 2015), thus providing 
the basis for an automatic method for characterising PB. 
There is a great deal of variability in the response to hypoxia, including the onset of PB, 
whose origin is still poorly understood. The variation cannot be explained by environmental 
factors alone.  There is also a genetic component (Strohl, 2003). In two different mice strains 
exposed to the exact same conditions, only one exhibited post-hypoxic PB. It is now 
accepted that genetics plays an important role in the hypoxic ventilatory response (HVR), 
demonstrated in humans by family and population studies (Weil, 2003; Teppema and 
Dahan, 2010; Hennis et al., 2015). Although genetics is closely linked to the hypoxic 
response, the exact genes involved, and their specific contributions remains to be 
elucidated. 
The aim of the present study was to examine the oscillatory characteristics of hypoxic 
periodic breathing, both in normobaric and hypobaric conditions, with particular focus on 
the phase coherences and phase shifts among oscillations in the heart rate, respiration and 
the microvascular flow. Furthermore, it was intended to test the hypothesis that common 
functional genetic polymorphisms in selective antioxidative (SOD2, CAT and GPX) and 
neurodevelopmental (NOTCH4 and BDNF) genes are statistically linked to features of these 
oscillations, such as their phase coherences. This could then elucidate whether genetic 






The study protocol was registered at ClinicalTrials.gov (NCT02780908) and approved by the 
National Committee for Medical Ethics of the Republic of Slovenia (0120-101/2016-2). In 
addition to this ethical approval, which covered the whole experiment (all laboratories in 
SLO & FR), local approval was obtained through the Ifremmont  (Institut de formation et de 
recherche en médecine de montagne) for the experiments conducted in Chamonix (France). 
All experimental procedures were conducted in line with the standards set by the latest 
version of the Declaration of Helsinki. The participants were given detailed verbal and 
written instructions regarding all experimental procedures and any possible risks involved 
prior to the experimental protocol. Written informed consent was obtained from all 
participants before the start of the first measurements. 
 
Experimental design 
22 healthy subjects were recruited for the study and monitored in five different 
environments: normobaric normoxia (NN), normobaric hypoxia (both acute (NHa) and after 
6 hours of exposure (NH)), and hypobaric hypoxia (both acute (HHa) and after 6 hours 
exposure (HH)). All locations and measurement conditions are shown in Table 1. 
Participants were all male, aged 21 ± 1.6 years. BMI (22.5 ± 3.0 kg/m2), blood pressure 
(systolic (126.2 ± 6.6), diastolic (77.8 ± 8.3 mmHg)), body fat (19.9 ± 7.7%), height (1.75 ± 
0.08 m) and body mass (68.94 ± 7.48 kg) were also recorded during the first preliminary visit 
to Ljubljana, with all subjects being well-rested. Participants were first tested in a random 
order during normobaric normoxia (NN) and acute normobaric hypoxia (NHa) in a laboratory 
in Ljubljana, situated at an altitude of 300m. During the normoxic exposure the participants 
inspired ambient air, while during the acute normobaric hypoxic (NHa, simulated altitude) 
exposure they inspired a humidified hypoxic gas mixture (FiO2 = 0.13, PiO2 = 91 mmHg; Table 
1) from a 200-L Douglas bag via a two-way low resistance valve (2700 NRBV; Hans Rudolph 
Inc., Shawnee, KS) connected to an oro-nasal mask (Vmask, Hans Rudolph, Shawnee, USA). 
The prolonged normobaric hypoxic (NH) session was performed in the normobaric hypoxic 
facility in Planica (Rateče, Slovenia). The participants remained in the laboratory under 
normobaric hypoxic conditions FiO2 = 0.14, PiO2 = 90 mmHg; Table 1) for six hours prior to 
the measurements. As detailed elsewhere (Debevec et al., 2014), the normobaric hypoxic 
environment within the laboratory is generated and maintained using a Vacuum Pressure 
Swing Adsorption system (b-Cat, Tiel, The Netherlands). Acute and prolonged exposure 
sessions in hypobaric hypoxia (HH, terrestrial altitude) were subsequently performed at a 
high-altitude laboratory situated at the top of Aiguille du Midi Mountain (Chamonix, France; 
see Table 1 for details). The participants were taken to the laboratory using a cable car 
without any physical exercise and performed an acute test immediately upon arrival (HHa), 
and the prolonged exposure test after six hours of altitude exposure (HH). 
For safety purposes a medical doctor was present during all hypoxic exposures conducted in 
Ljubljana, Planica and Aiguille du Midi laboratories. The participants were constantly 
equipped with their personal finger oximetry device (3100 WristOx, Nonin Medicals, 
Minnesota, USA) in order to monitor heart rate and capillary oxyhemoglobin saturation 
responses. Should the participants experience any adverse physiological effects they would 
be disconnected from the hypoxic gas mixture (Ljubljana laboratory), removed from the 
hypoxic room (Planica laboratory) or would descend by the cable car to the lower altitude 
(Aiguille du Midi laboratory). During prolonged normobaric hypoxic exposures in Planica the 
participants also wore portable ambient O2 concentration analysers (Rae PGM-1100, 
California, USA) which activated a safety audible alarm if the O2 levels decreased below the 
pre-set levels. 
Electrocardiograms (ECG), respiration and skin blood flow at both wrists were measured for 
30 min for each subject in each condition. Respiration was measured using an adjustable 
Velcro belt incorporating a TSD201 conductance transducer (BIOPAC, California). The 
recorded signal is proportional to the expanding and contracting volume of the thorax as 
generated by breathing. Blood flow signals were measured using laser Doppler flowmetry 
(LDF) (DRT4, Moor Instruments, UK). Before data analysis, LDF signals were inspected, and 
movement artefacts were removed using linear interpolation. ECG and respiration signals 
were recorded at a sampling frequency of 1200 Hz, and blood flow signals at a sampling 
frequency of 40 Hz. Not all participants attended all measurements; sample sizes are shown 







Group Location Sample Altitude FiO2 (%) PiO2 BP 
size (m) (mmHg) (mmHg) 
NN Ljubljana 
(normoxia) 
22 300 0.21 146 743 
NHa Ljubljana 
(hypoxia) 
22 ≈ 3800 0.13 91 743 
NH Planica 18 ≈ 3840 0.14 90 684 
HHa Aiguille du 
Midi 
16 3842 0.21 90 478 
HH Aiguille du 
Midi 
13 3842 0.21 90 478 
Table 1 - Recording location information for all groups. NN – controls (normobaric normoxia), NHa – acute normobaric 
hypoxia (simulated altitude), NH – prolonged normobaric hypoxia (simulated altitude), HHa – acute hypobaric hypoxia 
(real/terrestrial altitude), HH – prolonged hypobaric hypoxia (real/terrestrial altitude). In acute hypoxic states, recording 
commenced at the onset of hypoxia. Data from prolonged hypoxic states were recorded following 6 hours of 
acclimatisation. FiO2: Fraction of inspired O2; PiO2 : Partial pressure of inspired O2; BP: Barometric (ambient) pressure. 
All datasets with simultaneously recorded signals for each participant and each condition 
(normoxic and hypoxic), including the genetic information collected from each participant 
(for details see below), are available at the Publications and Research (Pure) portal on 




For each subject a 5ml sample of peripheral blood was collected into a tube with sodium 
citrate and stored at -70oC. Genomic DNA was isolated from peripheral blood leukocytes 
using FlexiGene DNA kit (Qiagen, Hilden, Germany) according to the manufacturer's 
instructions. SOD2 rs4880, CAT rs1001179, BDNF rs6265 and NOTCH rs367398 
polymorphisms were genotyped using KASPar assays (KBiosciences, Herts, UK and LGC 
Genomics, UK) while GPX1 rs1050450 polymorphism was genotyped using TaqMan (Applied 
Biosystems, Thermo Fisher Scientific, USA) according to the manufacturer's instructions. 
 
Time-frequency analysis 
The inherent time-variability of biological systems means that to understand the state of the 
system properly, the dynamics must be recorded over a sufficiently long interval to 
characterise the oscillations present.  It is also necessary to apply analysis methods that, 
unlike the Fourier transform, take into account frequency variations over time. 
Wavelet analysis is used to obtain time-frequency representations of data. It is an optimal 
choice for the analysis of biological oscillations, enabling a sound analysis when there are 
both high- and low-frequency components present, due to the logarithmic frequency 
resolution and the adaptive window size. It has already been applied successfully in previous 
studies of periodic breathing in new-born infants (Mohr et al., 2015), during sleep apnoea 
(Figliola and Serrano, 1997; Figliola et al., 2003), and during exercise (Garde et al., 2015). 
The continuous wavelet transform (CWT) is, 










where 𝑔(𝑠, 𝑡) are complex coefficients obtained from the convolution of the wavelet 𝜓 with 
the time series. 𝜓 is the mother wavelet, which is scaled by the factor 𝑠 and translated in 
time by 𝑡. Here, we use the complex Morlet wavelet. For each point in time, and for each 
frequency, we obtain both a wavelet amplitude and a wavelet phase. We define wavelet 
power as the square of the wavelet amplitude. Biological oscillations do not usually have 
perfectly constant frequency, but, rather, they vary in time around certain values. The 
frequency at each moment in time is called the instantaneous frequency. The wavelet 
amplitudes provide information about the presence of oscillations at specific frequencies in 
the data and describe how the instantaneous frequencies change over time. This 
information can be obtained by ridge extraction (Iatsenko et al., 2016), allowing the 
dynamics of individual oscillators to be isolated, and then used in further analysis. Figure 1 
demonstrates the extraction of the time-varying heart rate from the ECG signal. The 
frequency of the heartbeat is traced in time, and this time series then specifies the 
instantaneous heart rate (IHR). 
It is also possible to extract the phase associated with each frequency at each time, 
information that forms the basis of phase coherence. Given two signals, phase coherence 
evaluates how constant their phase difference at each frequency remains over time. If the 
phase difference is almost constant, the phase coherence will tend towards 1. A 
monotonically varying phase difference will result in a phase coherence closer to zero. An 
example calculation of the phase coherence 𝐶𝛷 is shown in Figure 2 (a)-(c), whose 𝐶𝛷 is 
defined as (Bandrivskyy et al., 2004; Bernjak et al., 2012; Sheppard et al., 2012), 
𝐶𝛷(𝑓𝑘) =  √〈cos 𝛥𝛷𝑘,𝑛〉2 + 〈sin 𝛥𝛷𝑘,𝑛〉2, 
Here 𝛥𝛷𝑘,𝑛 = 𝛷2,𝑘,𝑛 − 𝛷1,𝑘,𝑛 and 𝛷1,𝑘,𝑛 and  𝛷2,𝑘,𝑛 are the instantaneous phases 
calculated at each time  𝑡𝑛 and frequency 𝑓𝑘. 
We have investigated the relationship between breathing and heart rate, including the 
phenomenon known as respiratory sinus arrhythmia (RSA). An example of this phenomenon 
can be seen in Figure 2 (d). There are clear oscillations of a similar frequency in both signals. 
Phase coherence quantifies the extent to which these two oscillations are related. 
The instantaneous heart rate (IHR) for each subject in each condition was extracted from 
the ECG signal using ridge extraction in the frequency range 0.5 - 2Hz. The ECG signals were 
resampled to 40Hz before the extraction. The mean and standard deviation of the IHR time 
series were calculated for each subject. The instantaneous respiration rate was extracted in 
a similar way, but in the frequency range 0.145 - 0.6Hz. 
Even in completely incoherent systems, non-zero coherence values may still be obtained, 
especially at low frequencies where a reduced number of available cycles results in 
artificially increased coherence. To correct for this bias, and to ascertain whether obtained 
coherence values are significant, surrogate data testing is required (Theiler and Prichard, 
1996; Schreiber and Schmitz, 2000; Sheppard et al., 2012; Lancaster et al., 2018). Surrogates 
attempt to mimic all the properties of the signal except the one being tested, in this case 




The functions used during the analysis are available to download as part of the Multiscale Oscillatory 
Dynamics Analysis (MODA) toolbox from https://github.com/luphysics/MODA.   
 
Heart rates – All ECG time series, having been down sampled from 1200 Hz to 40 Hz, were 
input into the ridge extraction function, choosing a frequency range of 0.5 – 2 Hz in which to 
extract the instantaneous heart rate (IHR). This provided an output of time series of the 
variability of the heart rate over time of the same length as the original signal, one for each 
subject in each condition (i.e. NN, NH etc.). For each time series, the mean, standard 
deviation and coefficient of variation values were calculated, and these values were then 
compared for significant differences between experimental conditions using the Kruskal 
Wallis and rank-sum tests, which compare the medians of the groups (see Figure 3). 
 
Respiration rates – The same procedure was followed as for the heart rates above, but the 
frequency range selected was 0.145 - 0.6Hz (also see Figure 3). 
Wavelet transforms of respiration and instantaneous heart rates – All wavelet transforms 
were calculated using the wavelet transform option in the time frequency analysis function 
in MODA. The frequency range in which the transform was calculated was 0.005 – 2 Hz. The 
central frequency of the wavelet used was 1. Pre-processing was set to ‘on’ (see MODA 
manual for further details). Respiration signals were down sampled from 1200 Hz to 40 Hz, 
IHR signals were already sampled at 40 Hz following ridge extraction. All respiration signals 
and all IHR signals for each subject in each condition were wavelet transformed, using the 
default wavelet function, which is a lognormal wavelet.  
This provides, for each signal, a matrix of complex coefficients with information about both 
frequency and phase at each point in time. The amplitude coefficients were squared and 
averaged in time (mean), providing a time-averaged wavelet power within the frequency 
range specified. These time averages were then averaged for all subjects for each condition, 
providing the graphs for mean wavelet power shown in Figure 5 (a) & (b). 
 
Phase coherence - The coefficients generated in the previous step are then used to calculate 
wavelet phase coherence using the phase coherence function in MODA. To calculate phase 
coherence between respiration and IHR, the IHR and respiration signals were input to the 
function for each subject in each condition. This provides the phase coherence in the same 
frequency range, 0.005 – 2 Hz, and also the phase difference at these frequencies. Again, 
the results were averaged in time for each subject and condition, and then averaged across 
subjects to provide the graphs shown in Figure 5 (c) & (d). The same methods were used to 
calculate the phase coherence between the blood flow signals and the IHR and respiration 
shown in Figure 8, although only the frequency range 0.03 Hz - 0.5 Hz is shown. 
The main differences in phase coherence between IHR and respiration were found in the 
frequency range 0.03 - 0.15 Hz, which is referred to as the modulation band. Single 
coherence values within this band were obtained by calculating the mean of the time-
averaged phase coherence for each subject in each condition within this frequency band. 
These single values were then used for comparison between conditions, as seen in Figure 7, 
and for comparison with genetic results, as seen in Figure 9. 
 
Genetic results – Each subject underwent testing for the specific genes described earlier in 
the text. The single, averaged phase coherence values obtained above from the modulation 
band were grouped according to whether the subject had a normal, heterozygous or 
homozygous (only in NOTCH) result. Significant differences in these groups were then 





IAAFT surrogates were used in wavelet phase coherence calculations to assess significance. 
Wavelet phase coherence was considered significant if it was above the 95th percentile of 
100 iterative amplitude adjusted Fourier transform (IAAFT) surrogates (Schreiber and 
Schmitz, 2000). All phase coherence values presented have had this surrogate threshold 
subtracted. The statistical significance between groups was evaluated using non-parametric 
tests, to avoid the assumption of normal distributions in the data. To compare between 
more than two groups the Kruskal Wallis test was used and, if significant differences were 
found, they were further investigated using the Wilcoxon rank-sum test. The null hypothesis 
for both tests is that the sample groups have the same median. All statistical tests were 




Heart and respiration rates 
Mean heart rates differed significantly between groups (p = 0.0000) (Figure 3 (a)). During 
sustained hypoxia (NH and HH) the heart rates were significantly higher than in the 
normoxic state (NN). However, they were not significantly higher than in normoxia during 
either acute normobaric (NHa) or acute hypobaric hypoxia (HHa). Significant differences 
were also observed between the standard deviations of the IHR (p = 0.0005), shown in 
Figure 3 (c). The variability of the heart rate was significantly higher during HHa and HH than 
during normoxia, but there was no significant difference in variability between NH and NN. 
The coefficient of variation (CV) of the heart rate differed significantly between groups (p = 
0.0453), and is shown in Figure 3 (e). It is also known as relative standard deviation and is 
defined as the ratio of standard deviation of the heart rate to its mean. It was highest during 
acute hypobaric hypoxia (HHa). It is obvious that the variability (standard deviation) of the 
heart rate is not linearly related to the actual heart rate. 
Similarly, the instantaneous respiration rate was extracted by ridge extraction, and its mean 
and standard deviation over time were calculated. The group medians are shown in box 
plots in Figures 3 (b)&(d). Mean respiration rates were significantly different between 
groups (p = 0.0000). The results show that the mean respiration rate significantly increased 
from normoxia during sustained hypoxic conditions, but not during acute hypoxia. Mean 
respiration rates did not differ significantly between prolonged normobaric hypoxia (NH), 
acute hypobaric hypoxia (HHa) and prolonged hypobaric hypoxia (HH). A significant 
difference was also observed in the standard deviation of the respiration rate (p = 0.0006). 
This was caused by a significant reduction in the standard deviation of respiration rate 
during NHa only (Figure 3 (d)). The CV of the respiration rate (Figure 3 (f)) did not differ 
significantly between groups (p = 0.2931), indicating that the variability (standard deviation) 
of the respiration rate is almost linearly related to the actual respiration rate. 
 
Periodic breathing 
A regular, low-frequency oscillation at a frequency below that of breathing emerged 
intermittently in most subjects during sustained normobaric and hypobaric hypoxia, and 
was identified as arising from PB; an example respiration signal from one subject is shown in 
Figure 4 (b), and its wavelet transform in Figure 4 (d). The wavelet transform of the 
respiration signal during PB shows two distinct oscillations, one at the respiration frequency 
(≈0.35 Hz) and one at the modulation frequency (≈0.05Hz). The frequency of modulation 
varied slightly between subjects and conditions but did not vary significantly (p = 0.799).  
Time-averaged wavelet transforms of the respiration signals for all subjects in each state are 
compared in Figure 5 (a). A low-frequency peak is clearly visible around 0.058 Hz in the 
mean spectra of all hypoxic states except NHa, in addition to peaks at the respiration 
frequency (≈0.3 Hz in hypoxia). Note that the mean respiratory frequency is significantly 
higher during NH and HH conditions when compared to NN. Also at the respiration 
frequency, the group mean of the time-averaged wavelet power of the respiration signal is 
higher in prolonged (NH, HH) than in acute (NHa, HHa) states. 
 
Heart rate variability 
Heart rate variability (HRV) was analysed in terms of the time-averaged wavelet power 
spectrum of the IHR signal. The mean HRV for each group is compared in Figure 5 (b). As 
also observed in the respiration, a significant peak in the HRV around 0.05/0.06 Hz appears 
during all hypoxic states except acute normobaric hypoxia (NHa, orange line). This peak is 
more pronounced in HHa and HH, which may explain the increased standard deviation of 
IHR observed in these groups. During hyperventilation the heart rate is usually higher than 
during apnoea, as illustrated in Figure 6, similar to the results by Franklin et al., 1997 in 
Cheyne-Stokes respiration of patients with heart failure. 
 
Phase coherence for IHR and respiration 
To investigate the relationship between IHR and respiration, and whether or not the low-
frequency peaks observed in the spectra of the respiration and heart rate signals are 
related, wavelet phase coherence was calculated between the respiration signal and the 
instantaneous heart rate extracted from the ECG for each subject in each condition. This 
phase coherence will sometimes be referred to as cardiorespiratory (CR) coherence. Results 
are shown in Figure 5 (c). A low-frequency peak in the coherence can be observed clearly in 
the range 0.03 - 0.1 Hz in all states except normoxia. This indicates coherence at frequencies 
corresponding to that of the resulting the modulation associated with PB. It suggests that 
the physiological mechanism involved in the modulation is simultaneously present in both 
signals. Although the general trend shows that IHR-respiration coherence is increased 
during hypoxia, this is not the case for all subjects. Results for the 13 individuals that 
attended all measurements are shown in Figure 7. 
The phase difference can also be used to determine which of two coherent oscillators is 
leading, and thus more likely to be the origin of the dynamics. The group means of the time-
averaged phase difference for each condition are shown in Figure 5 (d). As would be 
expected due to RSA, the respiration signal leads within the respiratory frequency band 
(around 0.25 Hz under control conditions and up to 0.33 Hz in prolonged hypoxia), as 
demonstrated by the positive phase difference in all 5 conditions. In the modulation of 
respiration frequency band the coherence is higher in all cases of hypoxia compared to 
normoxia. In this band the phase difference is slightly positive during hypoxia  (with the 
exception of NHa where the smallest power of PB was observed), indicating that the 
mechanism giving rise to the component in this band in both signals is driving the 
respiration slightly ahead of driving the heart rate. 
 
Blood flow 
Low-frequency oscillations were also observed in the time-averaged wavelet transforms of 
skin blood flow recordings. To investigate their origins, wavelet phase coherence was 
calculated between the LDF signals and both the instantaneous heart rate and the 
respiration signals. Significant coherence was found in all comparisons, as shown in Figure 8, 
together with the corresponding time-averaged phase differences. 
Coherence between the respiration and blood flow signals (Figure 8 (c),(d)) was found at 
both the modulation frequency and the respiration frequency. Phase coherence at the 
modulation frequency was much smaller in the normoxic case, suggesting that this 
coherence may be due to the effects of the PB mechanism on the respiration and blood 
flow. In contrast, phase coherence between the IHR and blood flow (Figure 8 (a),(b)) at the 
modulation frequency was high even during normoxia, suggesting that an oscillation at the 
PB modulation frequency may be present even during normoxia, albeit much weaker. The 
phase differences in Figure 8 also yield the following important insights. In all four 
comparisons, there is a clear difference between the phase shifts at the respiration 
frequency and at the modulation frequency, with the blood flow clearly lagging behind in 
phase at the respiration frequency, except in the comparisons between respiration and 
blood flows in the case of prolonged normobaric hypoxia. This suggests that the periodic 
breathing has a different physiological mechanism from that of the normal respiratory cycle. 
 
Associations between genetic factors and periodic breathing 
We have shown an increase in coherence between the instantaneous heart rate and 
respiration during hypoxia within frequency band related to periodic breathing. The genetic 
information collected from each participant allows us to investigate whether any of the 
genes considered may be related to the hypoxic response. Mean cardiorespiratory (CR) 
coherence over the modulation band (0.03 - 0.15 Hz) was calculated for each subject in each 
of the 5 states, and divided into groups depending on the results for specific genes.  No 
significant differences (in all cases p > 0.5) were found for the SOD2, BDNF and GPX1 
polymorphisms, suggesting that they are not related to cardiorespiratory phase coherence 
in the modulation frequency band. Results for the NOTCH4 and CAT polymorphisms are 
shown in Figure 9. Here, a significant difference was found for NOTCH4 polymorphisms 
during hypoxia, with carriers of NOTCH4 having significantly higher CR coherence, and thus 
more periodic breathing, in all hypoxic conditions except NHa. In contrast, significantly lower 
CR coherence was found during hypoxia in carriers of CAT. Interestingly, the significance of 
this difference was only observed during hypobaric hypoxia, both acute and prolonged, with 
no significant differences being found during normoxia or normobaric hypoxia. 
The genetic results were also compared to the altitudes of the permanent places of 
residence of each subject in Table 2. Although difficult to quantify correlations, there 
appears to be a tendency for the normal results for NOTCH4 (GG) to occur in those living at 











Subject Altitude (m) NOTCH4 CAT 
17 199 GG CT 
18 199 GG CT 
20 235 AA CT 
15 260 GA CC 
1 262 GA CC 
11 295 GA CC 
12 295 GG CC 
16 295 GA CT 
21 295 GA CT 
22 295 GA CT 
4 295 GG CT 
5 295 GG CT 
6 295 GG TT 
7 300 GA CT 
13 380 GA CC 
14 380 GA CC 
8 380 GG CC 
9 380 GA CT 
2 466 GA CC 
3 492 GA CC 
10 531 AA CT 
19 683 AA CC 
Table 2 - Table of altitudes of permanent residence for each subject, and the results of the genetic tests for NOTCH4 and 




The aim was to examine the effect of hypoxia on cardiovascular dynamics, including phase 
coherence and phase shifts between oscillations of the instantaneous heart rate detected 
from the ECG, of the respiration as detected from the respiratory effort, and the oscillations 
in the blood flow signal recorded by LDF. We also asked whether the cardiorespiratory 
coherence in the frequency interval of periodic breathing is related to polymorphism in 
specific genes. The four principal findings were: (1) normobaric and hypobaric hypoxia 
change heart and respiration rates, and their variabilities, (2) there is increased 
cardiorespiratory coherence during the episodes of periodic breathing, (3) the phase shifts 
between the IHR and respiration, on one side and microvascular blood flow on the other, 
are much smaller (almost zero) at the PB frequency, compared to the shifts at the 
respiration frequency, and (4) during hypoxia the cardiorespiratory coherence in the PB 
frequency interval is correlated proportionally to NOTCH4 and is inversely proportional to 
the CAT polymorphism. Below we discuss the effects of hypoxia on various parameters 
related to cardiovascular dynamics. 
 
Heart and respiration rates and their variability 
We have found significant differences in heart rates and respiration rates in subjects 
exposed to hypoxia, both normobaric and hypobaric. The hypoxia-induced increase in 
resting heart rate is a known phenomenon, and seems to result from a decrease in vagal 
outflow and an increase in relative sympathetic activity (Botek et al., 2015; Cornolo et al., 
2004). Significant differences were also found in the standard deviations of heart rates 
when comparing normoxia with both acute and prolonged hypobaric hypoxia, but not 
during normobaric hypoxia. The coefficient of variation indicated that the changes in heart 
rate variability (as quantified by their standard deviation) are not proportional to the 
changes of mean heart rate. Standard deviations of respiratory rates varied significantly 
from normobaric normoxia in all states but were almost proportional to the mean 
respiratory rates. These results demonstrate significant changes in the variation of heart and 
respiratory rates during hypoxia, and further investigations demonstrated that these are 
due, at least in part, to the presence of periodic breathing. 
The identification of PB from time series is not a trivial problem, and usually requires the 
input of a specialist on a case by case basis. Similarly to Garde et al. (Garde et al., 2015), we 
used the coherence between the respiration and the heart rate in the modulation frequency 
band to quantify PB during hypoxia. Because the heart rate is significantly influenced by the 
respiration via RSA, the distinctive periodic breathing pattern observed during hypoxia is 
likely to have an effect on the heart rate. 
The direct effects of PB on the heart rate and blood pressure have been demonstrated using 
paced periodic breathing (Lorenzi-Filho et al., 1999, Francis et al., 2000), demonstrating that 
alterations in heart rate are a direct effect of respiratory modulation, and can occur without 
the need for hypoxia. This highlights the importance of taking the breathing dynamics into 
account when investigating heart rate variability, even during normoxic conditions and, 
moreover, demonstrates that paced respiration directly alters the natural dynamics of the 
cardiorespiratory system, leading to a forced state. 
It remains unclear whether the physiological responses to hypobaric (HH) and normobaric 
(NH) conditions are comparable (Millet et al., 2012). While a recent review (Coppel et al., 
2015) suggested that the majority of cardiovascular variable responses were similar 
between HH and NH, there is clear evidence that hypobaria per se can independently 
influence certain aspects of ventilatory (Faiss et al., 2013), and cardiac dynamics (Netzer et 
al., 2017) as well as its redox balance (Ribon et al., 2016) responses. Indeed, Heinzer et al. 
found that HH has a greater effect on nocturnal PB than NH (Heinzer et al., 2016). The 
results obtained in our study show that the heart rate is significantly increased during both 
normobaric and hypobaric sustained hypoxic states when compared to the normoxic state. 
However, heart rates do not differ significantly between normobaric and hypobaric hypoxia, 
suggesting that this difference is most likely due to the limited oxygen availability rather 
than the atmospheric pressure itself. In contrast, the standard deviation of the heart rate is 
only significantly different during hypobaric hypoxia. This suggests that the differences in 
heart rate variability cannot be explained by oxygen partial pressure differences alone, and 




Wavelet analysis was used to further investigate cardiorespiratory dynamics under different 
conditions. Both normobaric and hypobaric hypoxia induced PB, and we investigated the 
effects of this on the heart rate and the peripheral blood flow using wavelet phase 
coherence. Our results show that during PB, the heart rate is modulated not only at the 
respiration frequency, but also at the PB modulation frequency (see Figure 5). This confirms 
previous findings by (Garde et al., 2015) using time-frequency analysis to automatise the 
identification of PB. 
We also demonstrated significant wavelet phase coherence during hypoxic conditions, at 
the modulation frequency between respiration and blood flow recorded at each wrist, 
showing that PB dynamics propagates throughout the cardiovascular system. It was 
previously shown that forehead skin blood flow in new-borns oscillates with the rhythmicity 
of the breathing amplitude variation during PB (Jahnukainen et al., 1995). Our results also 
confirm the observations of Ovadia-Blechman et al., 2017 using cross-correlation analysis, 
which were attributed by the authors to a direct induction of vasomotion by slow 
respiration. 
The increased cardiorespiratory coherence (CRC) during periodic breathing could be an 
efficient adaptation to hypoxia. Possibly, increased CRC improves the efficiency of gas 
exchange. This finding could help in modelling the cardiorespiratory system, as the existing 
work (Ben-Tal et al., 2012; Ben-Tal and Tawhai, 2013; Ben-Tal et al., 2014; Molkov et al., 
2014; Ben-Tal et al., 2019) assumed periodic breathing was maladaptive rather than 
beneficial. 
Significant phase coherence was observed between the IHR and blood flow signals under all 
conditions. Using instantaneous phases, we were able to investigate phase differences and, 
for both respiratory and periodic breathing, the modulation phases showed a clear pattern 
relative to the blood flow recorded by LDF. Moreover, the pattern repeats for blood flow 
recorded on the left and the right arm. In all four comparisons, there was a clear difference 
between the phase shifts at the respiration frequency and those at the modulation 
frequency. While the blood flow is lagging behind at the respiratory frequency, there is 
minimal lag at the modulation frequency, indicating that the mechanisms underlying 
periodic breathing may operate at the microvascular level. This is further supported by the 
increased coherence at the PB modulation frequency observed in subjects with 
polymorphism in NOTCH4, which is involved in endothelial control of vascular modelling 
(Wu et al., 2005). Microvascular involvement may connect the observed dynamics indirectly 
to cellular respiration. While the exact mechanism remains to be elucidated, the results 
indicate that periodic breathing is of different physiological origin from the normal 
respiratory cycle. 
In addition to the heart beat and breathing, several other lower-frequency oscillatory 
processes are involved in the regulation of the cardiovascular system. Early studies of blood 
pressure regulation have identified ‘Mayer waves’, or ‘Traube-Hering-Mayer waves’ with a 
frequency of around 0.1 Hz in humans. They are associated with mechanisms of arterial 
blood pressure regulation with involvement of baroreceptors and chemoreceptors 
(Cherniack et al., 1969; Julien, 2006; Morris et al., 2010; Elstad et al., 2018). In the present 
study we based the analyses on the simultaneously recorded breathing, ECG and 
microvascular blood flow (also known as blood perfusion) measured by the LDF. Most 
studies to date have investigated LDF leading to the identification of oscillations of 
myogenic, neurogenic and endothelial origin (Stefanovska, 2007). Blood vessels that contain 
vascular smooth muscle cells are able to constrict and dilate independently (known as 
vasomotion) in order to control blood flow locally. This myogenic activity manifests in the 
frequency interval 0.052--0.145 Hz. Vasomotion may also be initiated by local vessel 
sympathetic innervation, known as neurogenic activity (0.021 - 0.052 Hz, (Soderstrom et al., 
2003). The slowest oscillations in blood flow (0.005 - 0.021 Hz) have been shown to result 
from endothelial activity (Kvandal et al., 2006). These frequency intervals for local 
regulatory activity were considered by Paparde et al., 2015 in their investigation of the 
effects of hypoxia on cutaneous blood flow dynamics.  Vascular-related mechanisms of 
regulation are potential candidates for providing the underlying mechanisms of periodic 
breathing. The frequency of modulation during periodic breathing is, as shown in e.g. Figure 
8, around 0.058 Hz,  most probably originating from the chemoreceptor-related sympathetic 
activity.  In the pattern of periodic breathing, Cheyne-Stokes respiration,  associated with 
central sleep apnoea in patients with heart failure, the modulation frequency is lower - 
between 0.01 Hz and 0.03 Hz, and has most probably its origin in NO-related endothelial 
activity - which is closely linked to cell energy metabolism. Alternatively, the Cheyne-Stokes 
respiration might have a similar origin to that periodic breathing in infants, but slower 
because of the much slower metabolism in subjects with heart failure. Further 
investigations are needed to elucidate which one of them is the main origin of the periodic 




Using cardiorespiratory phase coherence as a marker of PB, we have demonstrated a clear 
relationship between PB incidence during hypoxia and polymorphisms in NOTCH4 and CAT, 
with the former being associated with a larger effect of PB and the latter associated with a 
smaller effect of PB. The NOTCH signalling pathway has previously been shown to be 
positively modulated by hypoxia (Hiyama et al., 2011). We also identified a potential link 
between polymorphism in NOTCH4 and the altitude at which the subject resides, though 
this needs to be confirmed in a larger cohort. 
 
Methodological considerations 
The data presented here were recorded from individuals who were all born pre-term. Whilst 
this is not usually a factor that is considered during recruitment of healthy control 
participants for physiological research studies, it should be noted that pre-term individuals 
that were exposed to intermittent hypoxia have an enhanced ventilatory response to 
hypoxia (Nock et al., 2004), and a more recent study showed a blunted hypoxic ventilatory 
response in the same group of participants presented in this paper  (Debevec et al., 2019). 
Thus, it cannot be ruled out that the responses to hypoxia presented here are influenced by 
these effects. 
Analyses of the relationship between PB coherence and the results of genetic testing were 
performed blind to experimental conditions. 
 
Significance and implications 
High altitude physiology has been investigated for decades and has recently gained much 
attention (Davies et al., 2018; Ruggiero et al., 2018; Hoiland et al., 2019; Julian and Moore, 
2019; Simpson et al., 2019). Clear physiological differences have been demonstrated 
comparing the physiological parameters of highlanders, from Himalaya (Ruggiero et al., 
2018; Hoiland et al., 2019; Simpson et al., 2019) or Andes (Julian and Moore, 2019), with 
those of lowlanders, including faster recovery of peripheral muscle fatigue in Sherpas 
(Ruggiero et al., 2018), bringing phenotypical evidence for evolutionary adaptation in the 
control of cerebral blood flow and oxygen delivery at high altitude (Hoiland et al., 2019). A 
recent review suggested a need for further exploration of the interaction among genetic, 
epigenetic, and environmental factors in shaping patterns of adaptation to high altitude. 
Such a study promises to improve the understanding of the mechanisms underlying human 
adaptive potential and to clarify its implications for human health. By identifying the 
involvement of NOTCH4 and CAT we now provide evidence of specific gene polymorphisms 
related to the cardiorespiratory response to hypoxia. As NOTCH4 is related to the 
functioning of the vascular endothelium (Wu et al., 2005), our study supports the recent 
observation by Simpson et al., 2019 that mechanisms other than peripheral chemoreflex 
activation contribute to vascular sympathetic resetting at high altitude.  Furthermore, our 
study corroborates the findings by Davies et al., 2018, that differences in local 
microvasculature vasomotor and neurovascular control account for the ability of Sherpas to 
adapt to high-altitude hypobaric hypoxia by sustaining local perfusion and tissue 
oxygenation. The results of our study extend these recent findings by postulating that even 
smaller differences in altitude may lead to different genotypes and hence to different 
responses to hypoxia. 
Chronic periodic breathing is generally seen as an unfavourable state, being associated with 
increased mortality in chronic heart failure (Hanly and Zuberi-Khokhar, 1996; Lanfranchi et 
al., 1999) and poor prognosis in patients with Cheyne-Stokes respiration compared to those 
without (Naughton, 1998), but it may have some advantages in healthy people at high 
altitudes (Kupper et al., 2008). Hypoxia, as well occurring during acute ascents to high-
altitudes, is also a significant problem at sea-level, being a contributory factor in many 
pathological states including cancer (Eales et al., 2016), strokes (Hermann et al., 2007), and 
heart infarctions (Michiels, 2004). The similarities between hypoxia-induced PB at altitude 
and the breathing characteristics observed in certain pathological states provides an 
opportunity to further our understanding of the physiological processes involved in chronic 
hypoxic states that occur even when oxygen is abundant. Considering living systems as 
collections of interacting oscillators whose dynamics are governed by multiple underlying 
open systems enables the observation of functional changes over time, and investigation 
into how they are altered in health and disease. 
The term ‘periodic breathing’ is usually defined as: ‘clusters of breaths separated by 
intervals of apnoea (no breathing) or near-apnoea, as opposed to normal breathing which is 
usually regular’. However, in mathematics the term periodic function means a function 
returning to the same value at regular intervals. So, the term periodic breathing is 
misleading, because normal breathing is also periodic. As the intervals of regular breathing 
alternate with intervals of non-breathing, or apnoea (or near-apnoea), ‘periodic breathing’ 
can be seen as amplitude-modulated regular breathing. Therefore, we propose a slightly 
more descriptive term ‘periodically-modulated breathing’. 
The polymorphism correlations with phase coherence between instantaneous heart rate 
and respiration that are shown in this study may be used to better understand a range of 
questions in cardiorespiratory physiology - from mechanisms of pathological breathing 
(Dempsey et al., 2010), to the physiology and enhanced performance of breath holding in 
elite apneists (Bain et al., 2018). This novel approach brings together genetics, vascular 
physiology and neural control of cardiorespiratory function, and has great potential to help 




Quantification of periodic breathing during hypoxia using wavelet phase coherence provides 
a useful model for the study of low-frequency respiratory modulation and its effects on the 
whole cardiovascular system. Using this approach, we have demonstrated clear associations 
between polymorphisms in NOTCH4 and CAT and PB incidence. This provides specific 
evidence for a genetic basis for the wide variability in the hypoxic response and, crucially, 
identifies the specific genes involved.  This study illustrates how one can uncover the link 
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 Translational Perspective 
 
We tested the hypothesis that polymorphisms in selective antioxidative and 
neurodevelopmental genes are related to the mechanisms underlying the well-known onset 
of periodic breathing during hypoxia, which are not yet fully understood. By extracting 
features of phase coherences between oscillations in the heart rate, breathing and blood 
perfusion of tissues during periods of normoxia and hypoxia, we confirmed the existence of 
correlations with phase coherence between instantaneous heart rate and respiration and 
polymorphism in NOTCH4 and CAT during hypoxia-induced periodic breathing. In this way 
we found a specific link between structure (genetics) and function (phase coherence in 
cardiorespiratory oscillations).  Our methodology may be used to better understand a range 
of questions in cardiorespiratory physiology - from mechanisms of pathological breathing, 
such as sleep apnoea and Cheyne-Stokes breathing; to elucidating the link between genetics 
and function that results in differences in cardiorespiratory performance in highlanders and 
lowlanders; to establishing the link between function and genetics in reaction to hypoxia; 
and to the physiology and enhanced performance of breath holding in elite apneists, such as 
free divers.  Furthermore, mapping genes to function may help clinicians to understand and 
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Example extraction of instantaneous heart rate from the ECG signal. (a) Whole ECG time 
series. (b) Wavelet transform of the ECG signal in (a). A clear oscillatory mode around the 
expected heart rate (1 Hz) can be seen. (c) The time series of instantaneous frequency 
extracted from the wavelet transform using ridge extraction (for details see main text). (d) 
30 s portion of the ECG signal shown in (a), marked by vertical orange dashed lines. The 




Examples of phase coherence values. In (a–c), the black curve shows a sine wave of constant 
frequency 0.1 Hz. (a) The orange line shows a sine wave of the same frequency 0.1 Hz, so 
the phase coherence (PC) at 0.1 Hz is equal to 1, since the phase difference is constant over 
all time. (b) The orange wave is a sine wave of different frequency from that of the black 
wave, so the phase coherence at 0.1 Hz tends towards zero. (c) The orange wave has time-
varying frequency centred around 0.1 Hz: at some times the orange wave is coherent with 
the black, but less so at other times, and so the phase coherence value at 0.1 Hz is less than 
1 but more than 0. In reality, the frequency of a signal from a living system is not constant 
but varies over time. (d) Example of a real respiration signal (black) and the simultaneous 
instantaneous heart rate (IHR, red) signal after it has been extracted from the wavelet 
transform of the ECG as described in Figure 1. It is clear that there are oscillations in both 
signals, and that they are oscillating at a similar frequency. 
 
Figure 3 
Boxplots showing results for all groups. On each box, the central mark indicates the median, 
and the bottom and top edges of the box indicate the 25th and 75th percentiles, 
respectively. The whiskers extend to the most extreme data points not considered outliers, 
and the outliers are plotted individually using the ‘+’ symbol. (a) Mean heart rate (p = 
0.0000). (c) Standard deviation of the heart rates (p = 0.0151). (e) Coefficient of variation of 
heart rate (p = 0.0453). (b) Mean respiration rate (p = 0.0001). (d) Standard deviations of the 
respiration rate (p = 0.0002). (f) Coefficient of variation of the respiration rate (p = 0.2931). 
p-values are from the Kruskal Wallis test. NN – control conditions (normobaric normoxia); 
n=22, NHa – acute normobaric hypoxia (simulated altitude); n=22, NH – normobaric hypoxia; 
n=18, HHa – acute hypobaric hypoxia (real/terrestrial altitude); n=16, HH – hypobaric 
hypoxia; n=13. The same subjects were included on all 5 occasions, although some dropped 
out because they could not travel from Ljubljana, Slovenia either to Planica, Slovenia or to 
Aiguille du Midi, France, or felt unwell because of prolonged hypobaric hypoxia at Aiguille 
du Midi. * p < 0.05, ** p < 0.01, *** p < 0.001. 
 
Figure 4 
Continuous wavelet transforms of respiration signals during normoxia and normobaric 
hypoxia. (a) Breathing signal from one subject during normoxia. (b) Breathing signal from 
the same subject during sustained normobaric hypoxia (NH). Insets in (a) and (b) show 50 s 
samples of each time series. (c) Wavelet transform of the respiration signal in (a). (d) 
Wavelet transform of the respiration signal in (b). 
 
Figure 5 
Group means of the normalised time-averaged wavelet transforms for (a) respiration signals 
and (b) instantaneous heart rate (IHR) signals for each condition. (b) describes the nature of 
heart rate variability. (c) Group means of the phase coherence between the respiration and 
instantaneous heart rate signal, with the critical surrogate threshold subtracted. (d) Group 
means of the time-averaged phase difference for the coherence shown in (c) at each 
frequency, shown for significant coherence only. Dashed lines indicate 0.058 Hz, where an 
extra peak appears in both spectra during hypoxia, and 0.3 Hz, the approximate respiration 
frequency during hypoxia. NN – normobaric normoxia (n =22), NHa – acute normobaric 
hypoxia (n=22), NH – normobaric hypoxia (n=18), HHa – acute hypobaric hypoxia (n=16), HH 
– hypobaric hypoxia (n=13). 
 
Figure 6 
Respiration (top), ECG (middle), and heart rate (bottom) during NH-induced PB in subject 
S15. For the sake of clarity, the heart rate was plotted directly from the ECG, defined as an 
inverse of the time between consecutive R-R peaks. The normal heart rate for this subject 




Phase coherence between respiration and instantaneous heart rate averaged over the 
periodic breathing modulation frequency band (0.03 – 0.15 Hz) for all states for the 13 
subjects that attended all sessions. NN – normobaric normoxia, NHa – acute normobaric 
hypoxia, NH – normobaric hypoxia, HHa – acute hypobaric hypoxia, HH – hypobaric hypoxia. 
The linear connections between points are presented purely to help identify visually the 
changes for individual subjects, each represented by a different colour. 
 
Figure 8 
Group means of the phase coherence among instantaneous heart rate, respiration, and LDF 
at the two wrists. (a),(b) Phase coherence between the instantaneous heart rate and the 
blood flow signal recorded using LDF in (a) the left and (b) the right wrists, in the frequency 
interval between 0.03 Hz and 0.5 Hz, all with the critical surrogate threshold subtracted. 
(c),(d) Phase coherence between the respiration signal and the blood flow signal recorded 
using LDF in (c) the left and (d) right wrists, in the frequency interval between 0.03 Hz and 
0.5 Hz, all with the critical surrogate threshold subtracted. For each of the 4 cases, the group 
mean of the time-averaged phase difference is shown underneath the coherence plot. 
Dashed lines indicate 0.058 Hz and 0.3 Hz, the approximate modulation and respiration 
frequencies, respectively. NN – normobaric normoxia (n=22), NHa – acute normobaric 
hypoxia (n=22), NH – normobaric hypoxia (n=18), HHa – acute hypobaric hypoxia (n=16), HH 
– hypobaric hypoxia (n=13). 
 
Figure 9 
Boxplots of cardiorespiratory (CR) coherence in normoxia and hypoxia, grouped by genetic 
results for NOTCH4 and CAT. No significant differences were found during normoxia (NN) or 
acute normobaric hypoxia (NHa). During normobaric hypoxia (NH), the group of subjects 
with polymorphism in NOTCH4 showed significantly higher CR coherence. In contrast, 
subjects with polymorphism in CAT showed lower CR coherence during HH and HHa. p-
values are results of the Kruskal Wallis test. Significance is considered as p < 0.05, shown in 
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NN NHa NH HHHHa
NOTCH4
CAT
p = 0.791 p = 0.592 p = 0.013 p = 0.025 p = 0.046
p = 0.778 p = 0.181 p = 0.214 p = 0.012 p = 0.028
(a)
(b)



